Is Gilead Sciences, Inc. (NASDAQ:GILD) a Long Term Growth Play?

Marco Green
September 14, 2017

Carroll Financial Associates Inc. increased its position in Gilead Sciences by 1.2% during the 2nd quarter. Polianta Ltd now owns 17,400 shares of the biopharmaceutical company's stock worth $1,231,000 after acquiring an additional 3,300 shares during the period. Following the completion of the sale, the chief financial officer now directly owns 43,352 shares of the company's stock, valued at approximately $3,684,920.

Shares of Gilead Sciences (NASDAQ:GILD) traded down 0.98% during midday trading on Wednesday, hitting $83.68.

Stadion Money Management Llc increased Kellogg Co (K) stake by 18.79% reported in 2016Q4 SEC filing. The North Tide Capital Llc holds 500,000 shares with $35.81 million value, down from 800,000 last quarter. Macquarie Infrastructure Cor now has $6.08B valuation.

In related news, CFO Robin L. Washington sold 51,820 shares of the firm's stock in a transaction on Thursday, September 7th.

About 6,375 shares traded.

Mckinley Capital Management Delaware lessened its position in stocks of Gilead Sciences, (NASDAQ:GILD) by 9.9% in the 1st period, according to The corporation in its latest document with the Securities & Exchange Commission. It has underperformed by 9.03% the S&P500.

Veritable Lp decreased Interpublic Group Cos Inc (NYSE:IPG) stake by 15,273 shares to 303,553 valued at $7.11M in 2016Q4. It also reduced Corning (NYSE:GLW) stake by 229,818 shares and now owns 10,825 shares. Ishares Tr (IXC) was reduced too.

Since March 30, 2017, it had 0 insider purchases, and 7 sales for $16.39 million activity. 5,000 shares valued at $341,529 were sold by Alton Gregg H on Monday, May 1. $4.78 million worth of Gilead Sciences, Inc. Investors of record on Friday, September 15th will be issued a $0.52 dividend. Its up 0.02, from 0.91 in 2016Q3. (NASDAQ:GILD) was sold by MARTIN JOHN C. 111 funds opened positions while 421 raised stakes. Strs Ohio reported 1.46 million shares. 14,000 were accumulated by Markel. The biopharmaceutical company reported $2.56 EPS for the quarter, topping the Zacks' consensus estimate of $2.11 by $0.45. Virginia-based Bb&T Ltd Co has invested 0.01% in Badger Meter, Inc. 136,219 are owned by Meag Munich Ergo Kapitalanlagegesellschaft Mbh. Boothbay Fund Mngmt Ltd reported 7,598 shares. Duncker Streett Inc accumulated 3,363 shares. RI now owns 12,310 shares of the biopharmaceutical company's stock worth $836,000 after acquiring an additional 190 shares during the period. Jyske Bank upgraded Gilead Sciences, Inc. (NASDAQ:GILD). First Manhattan holds 2.68M shares. $668,667 worth of Gilead Sciences, Inc. Windsor Management Ltd holds 0.32% in Gilead Sciences, Inc. (NASDAQ:GILD). Coho Partners Ltd reported 1.04 million shares or 2.61% of all its holdings. Seabridge Investment Advsr Limited Co stated it has 0.26% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Valueworks Ltd owns 72,697 shares or 4.1% of their United States portfolio. ValuEngine cut shares of Gilead Sciences from a "buy" rating to a "hold" rating in a research note on Friday, June 2nd. Therefore 63% are positive.

Looking forward, the company's quarterly earnings are expected to come at $2.07 in the three months through September 2017 and $1.88 in the quarter ending December 2017, reflecting -23.33% and -28.79% growth, respectively. The stock has "Buy" rating by Jefferies on Wednesday, October 5. JP Morgan maintained it with "Overweight" rating and $90 target in Thursday, March 24 report. The company was maintained on Tuesday, July 25 by Piper Jaffray. The firm has "Buy" rating by Sidoti given on Tuesday, January 10. The rating was maintained by Needham on Wednesday, July 29 with "Buy". The firm has "Buy" rating given on Wednesday, August 12 by Stifel Nicolaus. Of Oklahoma reported 0% in Gilead Sciences, Inc. The firm has "Buy" rating by Berenberg given on Monday, September 12. Bank of America upgraded the stock to "Neutral" rating in Monday, January 18 report. Park National Corp OH increased its position in Gilead Sciences by 1.5% during the second quarter. Its down 0.04, from 0.87 in 2016Q3. It improved, as 29 investors sold MIC shares while 101 reduced holdings. 34 funds opened positions while 77 raised stakes. Lucas Cap Mgmt accumulated 0.47% or 9,095 shares. Finally, C WorldWide Group Holding A S lifted its position in shares of Gilead Sciences by 9.1% during the 1st quarter. Goldman Sachs has invested 0% in LendingClub Corp (NYSE:LC). Monroe National Bank & Tru Mi holds 0% or 69 shares. 299 were reported by Jnba Fincl. Charlemagne Cap Ltd has 6,472 shares. 574,949 are held by Invesco Ltd. Citadel Advsr Ltd Company holds 0% or 67,850 shares in its portfolio.

Nicholas Company Inc increased Ametek Inc. Moreover, United Asset Strategies Inc. has 0.68% invested in the company for 98,055 shares. Waters Parkerson And Communication Limited Liability, a Louisiana-based fund reported 4,000 shares. John G Ullman And Associate reported 1.98% stake.

Among 5 analysts covering Inogen (NASDAQ:INGN), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Badger Meter had 12 analyst reports since July 21, 2015 according to SRatingsIntel. Oppenheimer maintained the shares of GILD in report on Tuesday, October 20 with "Outperform" rating. The stock has "Buy" rating by Citigroup on Friday, August 5. On Thursday, August 31 the stock rating was initiated by William Blair with "Buy". The firm has "Outperform" rating by Credit Suisse given on Wednesday, September 14. The company was upgraded on Wednesday, November 4 by Credit Suisse. As per Wednesday, February 3, the company rating was maintained by RBC Capital Markets. The company was downgraded on Friday, April 29 by Maxim Group.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article